title: Thrombangitis obliterans: leucocyte subpopulations and circulating immune complexes.
abstract: BACKGROUND
  The etiology of thrombangitis obliterans is still unclear. Although cellular infiltration of the vessel wall is known, no studies on peripheral blood mononuclear cells are reported. Therefore, we assessed leucocyte subpopulations and circulating immune complexes in patients with thrombangitis obliterans and a control group of normal people.
  
  
  METHODS
  31 patients (40 +/- 2 years, 24 male, 7 female) with thrombangitis obliterans were included, based on the following criteria: age of manifestation, acral ischemia in legs and arms, previous thrombophlebitis or phlebitis saltans. Manifestation of atherosclerosis or other vasculitic manifestations were excluded. Leucocyte subpopulations, levels of C-reactive protein (CRP) and circulating immune complexes (CIC) were investigated. An age-matched control group (n = 25) was recruited from voluntary blood donors.
  
  
  RESULTS
  Leucocyte counts in the thrombagitis group (mean +/- SD: 10,839 +/- 782/nl) were significantly different from the control group (6205 +/- 414/nl, p < 0.0001). The same was true for absolute counts of granulocytes, monocytes and lymphocytes. The results were independent from CRP, which was elevated only in 6 patients. Relative counts of naive helper T-cells were significantly lower in the patient group. HLA-DR expression on B-cells was lower on the patients' lymphocytes. The concentrations of IgA, IgG and IgM in CIC were higher in the thrombangitis patients compared to the control group. C1q-binding capacity and phosphatidylserine antibodies showed no differences.
  
  
  CONCLUSIONS
  Patients suffering from thrombangitis obliterans show alterations of leucocyte counts and their subpopulations as well as alterations of the humoral (IgCIC) immune system.
authors.affiliation: Department of Angiology, University Hospital Essen, Germany. knut.kroeger@uni-essen.de
authors.forename: K
authors.initials: K
authors.lastname: Kröger
authors.forename: E
authors.initials: E
authors.lastname: Kreuzfelder
authors.forename: C
authors.initials: C
authors.lastname: Moser
authors.forename: F
authors.initials: F
authors.lastname: Santosa
authors.forename: C
authors.initials: C
authors.lastname: Buss
authors.forename: H
authors.initials: H
authors.lastname: Grosse-Wilde
mesh_terms: D000328:Adult; D000936:Antigen-Antibody Complex / Q000097:blood*; D001323:Autoantibodies / Q000097:blood; D015922:Complement C1q / Q000378:metabolism; D005260:Female; D006801:Humans; D007105:Immune Complex Diseases / Q000276:immunology; D018655:Lymphocyte Count; D008297:Male; D010718:Phosphatidylserines / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013919:Thromboangiitis Obliterans / Q000276:immunology*
chemical_list: D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D010718:Phosphatidylserines; D015922:Complement C1q